HighVista Strategies LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1335325 BOSTON, MA

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$897,771

-$237,521 QoQ

Shares Held

1,514

-35.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighVista Strategies LLC holds $12,144,053 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMLX	Amylyx Pharmaceuticals, Inc.	352,085	$4,893,981
2	LQDA	Liquidia Corp	99,744	$3,764,338
3	ALKS	Alkermes plc.	73,189	$2,587,963
4	UTHR	UNITED THERAPEUTICS Corp This page	1,514	$897,771

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$897,771	1,514	-35.0%	Shares	Sole	2026-05-15
2025-12-31	$1,135,292	2,330	+65.4%	Shares	Sole	2026-02-17
2024-06-30	$448,836	1,409	-38.7%	Shares	Sole	2024-08-14
2023-12-31	$505,527	2,299	0.0%	Shares	Sole	2024-02-14
2023-09-30	$519,275	2,299	+32.0%	Shares	Sole	2023-11-14
2023-06-30	$384,546	1,742	-45.6%	Shares	Sole	2023-08-14
2023-03-31	$717,567	3,204	0.0%	Shares	Sole	2023-05-15
2022-12-31	$891,000	3,204	-17.1%	Shares	Sole	2023-02-14
2022-09-30	$809,463	3,866	+12.0%	Shares	Sole	2022-11-14
2022-06-30	$813,429	3,452	+29.9%	Shares	Sole	2022-08-15
2022-03-31	$476,692	2,657	-57.6%	Shares	Sole	2022-05-16
2021-12-31	$1,353,957	6,266	+6.1%	Shares	Sole	2022-02-14
2021-09-30	$1,089,760	5,904	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.